Researchers develop peptide that can target tumors, deliver agents

10/27/2009 | EurekAlert!

Two University of Rhode Island researchers have developed a peptide called pHLIP that was able to locate a tumor in a mouse then deliver imaging and therapeutic agents to the cancer cells without harming surrounding healthy cells. The peptide's delivery method involves the use of a molecular nanosyringe that can deliver nanogold particles directly to the cancerous tumors. The technology has a pending patent in the U.S. and Europe.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN